ARMOR Study: COVID-19 Seroprevalence Among Healthcare Workers
SARS-CoV-2 Seroprevalence Among Healthcare Workers: ARMOR Study Demonstration Project
About This Trial
The novel coronavirus (SARS-CoV-2) has spread all around the world and testing has posed a challenge globally. Health care providers are highly exposed and are an important group to test. On top of these concerns, health care workers are also stressed by the needs on responders in the COVID-19 crisis. The investigators will look at different ways to measure how common COVID-19 is among health care workers, how common is the presence of antibodies by serological tests (also known as serostatus). The investigators will describe health worker mental and emotional well-being and their coping strategies in their institutional settings. Lastly, the investigators will describe how knowing serostatus can affect individuals' mental and emotional well-being and how to cope in the midst of the COVID-19 response. This will help to how to better test and help healthcare workers in the COVID-19 pandemic and prepare for possible future outbreaks.
Who May Be Eligible (Plain English)
Original Eligibility Criteria
View original clinical language
Treatments Being Tested
COVID-19 Serology
Quantitate Serology enzyme-linked immunosorbent assay (ELISA) for COVID-19
Health Care Worker Survey
The purpose of this survey is to assess how healthcare workers are experiencing and coping with the COVID-19 crisis.